Ragene Rivera

1.4k total citations
13 papers, 573 citations indexed

About

Ragene Rivera is a scholar working on Oncology, Cancer Research and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Ragene Rivera has authored 13 papers receiving a total of 573 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Oncology, 8 papers in Cancer Research and 4 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Ragene Rivera's work include Cancer Treatment and Pharmacology (9 papers), Breast Cancer Treatment Studies (8 papers) and Advanced Breast Cancer Therapies (3 papers). Ragene Rivera is often cited by papers focused on Cancer Treatment and Pharmacology (9 papers), Breast Cancer Treatment Studies (8 papers) and Advanced Breast Cancer Therapies (3 papers). Ragene Rivera collaborates with scholars based in United States, Switzerland and Chile. Ragene Rivera's co-authors include Adam Brufsky, Joyce O’Shaughnessy, Joanne L. Blum, Vicente Valero, Hope S. Rugo, N. D'Acosta, Fang Fang, John W. Smith, Ellen Chuang and Elizabeth Tan-Chiu and has published in prestigious journals such as Journal of Clinical Oncology, Cancer and Cancer Research.

In The Last Decade

Ragene Rivera

13 papers receiving 554 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ragene Rivera United States 10 473 197 142 90 47 13 573
Valorie F. Chan United States 7 653 1.4× 225 1.1× 318 2.2× 140 1.6× 14 0.3× 10 796
Rubi K. Li Philippines 8 575 1.2× 192 1.0× 112 0.8× 64 0.7× 9 0.2× 9 666
H Goulding United Kingdom 5 194 0.4× 133 0.7× 83 0.6× 185 2.1× 68 1.4× 7 429
Hongjian Yang China 14 282 0.6× 230 1.2× 91 0.6× 138 1.5× 105 2.2× 59 635
Pietro Gangemi Italy 12 164 0.3× 67 0.3× 27 0.2× 241 2.7× 21 0.4× 15 513
P. Ravdin United States 6 392 0.8× 220 1.1× 46 0.3× 92 1.0× 90 1.9× 7 515
Fumine Tsukamoto Japan 13 244 0.5× 156 0.8× 64 0.5× 107 1.2× 80 1.7× 28 445
I. Mandjes Netherlands 4 294 0.6× 32 0.2× 48 0.3× 94 1.0× 14 0.3× 4 408
Muhammad Alamgeer Australia 13 346 0.7× 176 0.9× 184 1.3× 294 3.3× 15 0.3× 25 615
K Hisamatsu Japan 12 229 0.5× 168 0.9× 74 0.5× 56 0.6× 66 1.4× 35 361

Countries citing papers authored by Ragene Rivera

Since Specialization
Citations

This map shows the geographic impact of Ragene Rivera's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ragene Rivera with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ragene Rivera more than expected).

Fields of papers citing papers by Ragene Rivera

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ragene Rivera. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ragene Rivera. The network helps show where Ragene Rivera may publish in the future.

Co-authorship network of co-authors of Ragene Rivera

This figure shows the co-authorship network connecting the top 25 collaborators of Ragene Rivera. A scholar is included among the top collaborators of Ragene Rivera based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ragene Rivera. Ragene Rivera is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

13 of 13 papers shown
1.
Espinosa, María Ángeles, et al.. (2024). S2120 Tirzepatide and MASLD: Real-World Outcomes in Patients With Overweight and Obesity. The American Journal of Gastroenterology. 119(10S). S1513–S1514. 2 indexed citations
2.
O’Shaughnessy, Joyce, Hartmut Koeppen, Yuanyuan Xiao, et al.. (2015). Patients with Slowly Proliferative Early Breast Cancer Have Low Five-Year Recurrence Rates in a Phase III Adjuvant Trial of Capecitabine. Clinical Cancer Research. 21(19). 4305–4311. 37 indexed citations
3.
Brufsky, Adam, Vicente Valero, B. Tiangco, et al.. (2012). Second-line bevacizumab-containing therapy in patients with triple-negative breast cancer: subgroup analysis of the RIBBON-2 trial. Breast Cancer Research and Treatment. 133(3). 1067–1075. 103 indexed citations
4.
O’Shaughnessy, Joyce, John Pippen, Devchand Paul, et al.. (2012). Adjuvant capecitabine for invasive lobular/mixed early breast cancer (EBC): USON 01062 exploratory analyses.. Journal of Clinical Oncology. 30(15_suppl). 547–547. 3 indexed citations
5.
Pippen, John, Devchand Paul, Christopher Stokoe, et al.. (2011). Randomized, phase III study of adjuvant doxorubicin plus cyclophosphamide (AC) → docetaxel (T) with or without capecitabine (X) in high-risk early breast cancer: Exploratory Ki-67 analyses.. Journal of Clinical Oncology. 29(15_suppl). 500–500. 9 indexed citations
6.
7.
8.
9.
Vahdat, Linda T., Brian Pruitt, Carol J. Fabian, et al.. (2009). Phase II Study of Eribulin Mesylate, a Halichondrin B Analog, in Patients With Metastatic Breast Cancer Previously Treated With an Anthracycline and a Taxane. Journal of Clinical Oncology. 27(18). 2954–2961. 201 indexed citations
10.
Jones, Stephen E., James Cantrell, Svetislava J. Vukelja, et al.. (2007). Comparison of Menopausal Symptoms During the First Year of Adjuvant Therapy With Either Exemestane or Tamoxifen in Early Breast Cancer: Report of a Tamoxifen Exemestane Adjuvant Multicenter Trial Substudy. Journal of Clinical Oncology. 25(30). 4765–4771. 63 indexed citations
11.
Blum, Joanne L., Brian Pruitt, Carol J. Fabian, et al.. (2007). Phase II study of eribulin mesylate (E7389) halichondrin b analog in patients with refractory breast cancer. Journal of Clinical Oncology. 25(18_suppl). 1034–1034. 7 indexed citations
12.
Baeza, Mercedes Rizo, Jose Reyes, Christie del Castillo-Hegyi, & Ragene Rivera. (2005). Post-Operative Adjuvant Radiochemotherapy in the Treatment of Gallbladder Cancer. International Journal of Radiation Oncology*Biology*Physics. 63. S285–S286. 10 indexed citations
13.
Rivera, Ragene, et al.. (1981). Hepatoma presenting as a retro-orbital metastasis. Cancer. 48(8). 1883–1885. 32 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Valorie F. Chan Breakdown of academic impact, for papers by Rubi K. Li Breakdown of academic impact, for papers by H Goulding Breakdown of academic impact, for papers by Hongjian Yang Breakdown of academic impact, for papers by Pietro Gangemi Breakdown of academic impact, for papers by P. Ravdin Breakdown of academic impact, for papers by Fumine Tsukamoto Breakdown of academic impact, for papers by I. Mandjes Breakdown of academic impact, for papers by Muhammad Alamgeer Breakdown of academic impact, for papers by K Hisamatsu
Rankless by CCL
2026